ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

22 hedge funds and large institutions have $13.7M invested in Oramed Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
5
Closed
6
Calls
$211K
Puts
$557K
Net Calls
-$346K
Net Calls Change
-$498K

Top Buyers

1
Stifel Financial
1
Stifel Financial
Missouri
$3.98M
2
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$212K
3
CA
3
Commerzbank Aktiengesellschaft
Germany
$164K
4
GIM
4
Greylin Investment Management
Virginia
$877K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$275K

Top Sellers

1
CCI
1
Columbus Circle Investors
$0
2
Jane Street
2
Jane Street
New York
$0
3
CS
3
Credit Suisse
Switzerland
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$129K
5
Barclays
5
Barclays
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Barclays
26
Barclays
United Kingdom
– – -10,989 Closed
AllianceBernstein
27
AllianceBernstein
Tennessee
– – -55 Closed
Northwestern Mutual Wealth Management
28
Northwestern Mutual Wealth Management
Wisconsin
– – -42 Closed
1
2